Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
3.050
-0.150 (-4.69%)
Apr 17, 2026, 4:00 PM EDT - Market closed
Regentis Biomaterials Market Cap
Regentis Biomaterials has a market cap or net worth of $15.8 million as of April 17, 2026.
Market Cap
15.80M
Enterprise Value
9.62M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.05
Market Cap Chart
Since the IPO on December 4, 2025, Regentis Biomaterials's market cap has decreased from $39.44M to $15.80M, a decrease of -59.94%. That is a compound annual growth rate of -91.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 15.80M | -54.75% |
| Dec 31, 2025 | 34.91M | -11.48% |
| Dec 4, 2025 | 39.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ekso Bionics Holdings | 38.52M |
| Nephros | 31.40M |
| Harvard Bioscience | 27.08M |
| Femasys | 25.60M |
| Milestone Scientific | 22.69M |
| Retractable Technologies | 20.06M |
| Jin Medical International | 15.65M |
| Bionano Genomics | 14.31M |